---
title: "Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference | ALC Stock News"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/271142901.md"
description: "Alcon CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on January 13, 2026, at 8:15 a.m. PST. A live webcast will be available at investor.alcon.com. Alcon is a global leader in eye care, offering a wide range of products that enhance sight and improve lives, impacting over 260 million people annually across 140 countries."
datetime: "2025-12-30T13:30:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/271142901.md)
  - [en](https://longbridge.com/en/news/271142901.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/271142901.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/271142901.md) | [繁體中文](https://longbridge.com/zh-HK/news/271142901.md)


# Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference | ALC Stock News

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST.

A live webcast of the conference will be available at investor.alcon.com/news-and-events/events-and-presentations.

**About Alcon**

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.

**Connect with us on  
**Facebook  
LinkedIn

View source version on businesswire.com: https://www.businesswire.com/news/home/20251229416794/en/

**Investor Relations**  
Daniel Cravens  
Allen Trang  
\+ 41 589 112 110 (Geneva)  
\+ 1 817 615 2789 (Fort Worth)  
investor.relations@alcon.com

**Media Relations**  
Steven Smith  
\+ 41 589 112 111 (Geneva)  
\+ 1 817 551 8057 (Fort Worth)  
globalmedia.relations@alcon.com  

Source: Alcon Inc. Investors

### 相关股票

- [Alcon (ALC.US)](https://longbridge.com/zh-CN/quote/ALC.US.md)

## 相关资讯与研究

- [Alcon Publishes Agenda for 2026 Annual General Meeting | ALC Stock News](https://longbridge.com/zh-CN/news/281575058.md)
- [A Look At Alcon’s (SWX:ALC) Valuation After Patent Infringement Ruling And Ongoing Royalty Obligations](https://longbridge.com/zh-CN/news/281164043.md)
- [Alcon publishes agenda for 2026 annual general meeting](https://longbridge.com/zh-CN/news/281579252.md)
- [Assessing Alcon (SWX:ALC) Valuation After Sustained Share Price Weakness](https://longbridge.com/zh-CN/news/280018529.md)
- [Sight Sciences U.S. District Court Issued Order On Post-Trial Motions In Patent Infringement Case Against Alcon Originally Filed On Sep 16, 2021](https://longbridge.com/zh-CN/news/281028480.md)